Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
Fiche publication
Date publication
décembre 2012
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ADOTEVI Olivier, Pr BORG Christophe, Dr GODET Yann
Tous les auteurs :
Godet Y, Dosset M, Borg C, Adotevi O
Lien Pubmed
Résumé
Insights into antitumor T-cell responses may help the development of more efficient treatments for lung cancer. The interplay between preexisting antitumor CD4(+) T-cell responses and platinum-based chemotherapy is crucial to improve patient survival. Accumulating evidence confirms that selecting cancer patients in whom chemotherapy can activate an anticancer immune response would largely improve the success of novel therapeutic approaches.
Référence
Oncoimmunology. 2012 Dec 1;1(9):1617-1619.